In a show of rare bipartisan agreement in the US Congress, lawmakers raised concerns over how the 340B program is driving up ...
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals ...
In this Leadership Dialogue conversation, Tina Freese Decker, president and CEO of Corewell Health and 2025 AHA board chair, joins Aimee Kuhlman, vice president of advocacy grassroots and government ...
CMS Finalizes 2.6% Payment Bump, Confirms Expansion of Site-Neutral Payments in 2026 OPPS Final Rule
CMS has issued a final OPPS rule for 2026, confirming a net 2.6% payment update, plans to expand site-neutral payment ...
The Orphan Drug Act has catalyzed innovation in rare disease treatments, but the law’s shortcomings — particularly around ...
Speaking to Airfinance Global this month, Nick Swenson, chief executive at the US-based aviation firm, said Air T will focus ...
The AHA said is primarily opposes the elimination of site-neutral cuts and the inpatient-only list proposed by CMS.
Anti-abortion organizations and Republican elected officials are searching for more ways to prevent Planned Parenthood from ...
The Apple iPad is great for mobile gaming if you're feeling cramped on your iPhone. And thankfully there's a massive list of ...
The $50 billion Rural Health Transformation Program has set up a hospital clash as states map out plans to support rural ...
Can ambulatory pharmacy drive growth? Healthcare leaders share strategies to optimize pharmacy models amid policy and market shifts.
Letters: A processor will butcher a deer at no cost to the hunter and provide the venison to local food banks for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results